Strongbridge Biopharma Receives Notice of Allowance from U.S. Patent and Trademark Office for New Patent
Juggernaut Announces Strategic Investment by Crescat Capital Funds for 28.95% Ownership - Dr. Quinton Hennigh Technical Advisor
